ARCHIVES

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984

Group Chairmen Cool To New Groups, Told Their Remarks Are Inappropriate

July 21, 1978

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

Large Bowel Study Expansion Hampered By Lack Of Coordination, NCI Admits

May 17, 1974

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995

Presidents’ FY93 Budget Holds NCI To $2 Billion, Gives NIH 5% Increase; Coalition ‘Disapionted’

February 7, 1992